Biotech · Private company · Cambridge, MA, US
Nanopathdx, Inc.
Track this companyFree. Adds Nanopathdx, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Multiplexed Assay for Point-of-Care UTI Diagnosis (ID/AMR)Fiscal year 2026 · $919.9KNIH RePORTER 5R44AI181154-03 · fetched Nov 12, 2026
- Multiplexed Assay for Point-of-Care UTI Diagnosis (ID/AMR)Fiscal year 2025 · $964.9KNIH RePORTER 5R44AI181154-02 · fetched Nov 12, 2026
- Multiplexed Assay for Point-of-Care UTI Diagnosis (ID/AMR)Fiscal year 2024 · $996.7KNIH RePORTER 1R44AI181154-01 · fetched Nov 12, 2026